课题基金 / 基金详情

Targeted intrapulmonary delivery of antiviral and immunomodulatory therapeutics to alleviate severe experimental H7N9 influenza-induced pneumonia

Targeted intrapulmonary delivery of antiviral and immunomodulatory therapeutics to alleviate severe experimental H7N9 influenza-induced pneumonia
靶向肺内递送抗病毒和免疫调节疗法以缓解严重的实验性 H7N9 流感诱发的肺炎
批准号:
318831
负责人:
Karniychuk Uladzimir
金额:
$8.47万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-11-01 至 2017-06-01

项目摘要

项目成果

Karniychuk Uladzimir的其他基金

相似基金

相关文献

中文摘要
翻译
每年有300万至500万受流感影响的个体发生严重的肺部炎症,这通常导致死亡。新的人畜共患流感病毒株如H7N9的出现增加了重症病例的数量。目前,雪貂被认为是最相关的动物,
英文摘要
Annually, 3-5 million influenza affected individuals develop severe lung inflammation which often leads to death. Appearance of new zoonotic influenza strains like H7N9 increases number of severe cases. At present, ferret is considered as the most relevan
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hematopoietic stem cell sequelae in fetuses and offspring exposed to in utero Zika infection
  • 批准号:
    433008
  • 项目类别:
    Operating Grants
  • 资助金额:
    $42.35万
  • 财政年份:
    2020
  • 负责人:
    Karniychuk Uladzimir
  • 依托单位:
The Bhagirath Singh Early Career Prize in Infection and Immunity: Hematopoietic stem cell sequelae in fetuses and offspring exposed to in utero Zika infection
  • 批准号:
    446143
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.91万
  • 财政年份:
    2020
  • 负责人:
    Karniychuk Uladzimir
  • 依托单位:
海外基金